Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro

B S Dwarakanath1

  • 1Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, New Delhi, India.

Insights

2-deoxy-D-glucose (2-DG) targets cancer cell metabolism by inhibiting glucose uptake and ATP production. This metabolic inhibitor shows promise as a therapeutic agent or adjuvant in cancer treatment, enhancing chemotherapy and radiotherapy efficacy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • 2-deoxy-D-glucose (2-DG) is a glucose analog investigated for its metabolic inhibitory effects.
  • It targets glucose transport and ATP production, impacting cellular energy.
  • 2-DG also influences N-linked glycosylation, protein folding, gene expression, and signaling pathways.

Purpose of the Study:

  • To explore the multifaceted effects of 2-DG on cellular metabolism and function.
  • To evaluate the potential of 2-DG as a therapeutic agent or adjuvant in cancer treatment.
  • To understand 2-DG's role in sensitizing tumor cells to existing therapies.

Main Methods:

  • Investigating 2-DG's impact on glucose metabolism and ATP production.
  • Analyzing 2-DG's effects on N-linked glycosylation and the unfolded protein response.
  • Evaluating cytotoxic effects (inhibition of proliferation, induction of apoptosis) in tumor cells.
  • Assessing 2-DG's synergistic effects with ionizing radiation and chemotherapy.

Main Results:

  • 2-DG depletes cellular energy by inhibiting glycolysis.
  • It induces unfolded protein responses and alters gene expression and protein phosphorylation.
  • Cytotoxic effects, including proliferation inhibition and apoptosis induction, were observed in various tumor cells.
  • 2-DG sensitizes tumor cells to radiotherapy and chemotherapy, enhancing treatment outcomes.

Conclusions:

  • 2-DG exhibits significant anti-cancer properties by targeting cellular metabolism.
  • Its ability to induce apoptosis and inhibit proliferation makes it a potential therapeutic agent.
  • 2-DG enhances the efficacy of conventional cancer treatments like radiation and chemotherapy.
  • Further development of 2-DG as a therapeutic or adjuvant is warranted.

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.3K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.6K
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.6K